Research Summary
Lipid nanoparticles (LNP) are a type of nanoparticle composed of a lipid outer layer and an inner core that can contain drugs, nucleic acids, or other molecules of interest. They are commonly used as drug delivery vehicles due to their ability to protect and transport therapeutic agents to specific sites in the body.
LNP have several advantages over traditional drug delivery methods. They can protect drugs from degradation in the bloodstream and increase their circulation time, allowing for targeted delivery to specific cells and tissues. They also have the ability to cross cell membranes and release their contents inside the target cells, increasing the efficiency of drug delivery.
LNP have been used in clinical trials for a variety of applications, including cancer therapy, gene therapy, and vaccine delivery. They have shown promise in improving the efficacy and safety of treatments for diseases such as cancer, infectious diseases, and genetic disorders.
According to DIResearch's in-depth investigation and research, the global Lipid Nanoparticles (LNP) market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Lipid Nanoparticles (LNP) include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical, Lipoid etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Lipid Nanoparticles (LNP). Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Lipid Nanoparticles (LNP) market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Lipid Nanoparticles (LNP) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Lipid Nanoparticles (LNP) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Lipid Nanoparticles (LNP) Include:
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Lipid Nanoparticles (LNP) Product Segment Include:
mRNA-lipid Nanoparticle
siRNA-lipid Nanoparticle
Others
Lipid Nanoparticles (LNP) Product Application Include:
Vaccines and Drugs
Scientific Research
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Lipid Nanoparticles (LNP) Industry PESTEL Analysis
Chapter 3: Global Lipid Nanoparticles (LNP) Industry Porter's Five Forces Analysis
Chapter 4: Global Lipid Nanoparticles (LNP) Major Regional Market Size and Forecast Analysis
Chapter 5: Global Lipid Nanoparticles (LNP) Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Lipid Nanoparticles (LNP) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Lipid Nanoparticles (LNP) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Lipid Nanoparticles (LNP) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Lipid Nanoparticles (LNP) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Lipid Nanoparticles (LNP) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Lipid Nanoparticles (LNP) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Lipid Nanoparticles (LNP) Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Lipid Nanoparticles (LNP) Market Overview 1.1 Product Definition and Statistical Scope 1.2 Lipid Nanoparticles (LNP) Product by Type 1.2.1 Global Lipid Nanoparticles (LNP) Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 mRNA-lipid Nanoparticle 1.2.3 siRNA-lipid Nanoparticle 1.2.4 Others 1.3 Lipid Nanoparticles (LNP) Product by Application 1.3.1 Global Lipid Nanoparticles (LNP) Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Vaccines and Drugs 1.3.3 Scientific Research 1.4 Global Lipid Nanoparticles (LNP) Market Revenue Analysis (2019-2030) 1.5 Lipid Nanoparticles (LNP) Market Development Status and Trends 1.5.1 Lipid Nanoparticles (LNP) Industry Development Status Analysis 1.5.2 Lipid Nanoparticles (LNP) Industry Development Trends Analysis 2 Lipid Nanoparticles (LNP) Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Lipid Nanoparticles (LNP) Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Lipid Nanoparticles (LNP) Market Analysis by Regions 4.1 Lipid Nanoparticles (LNP) Overall Market: 2023 VS 2024 VS 2030 4.2 Global Lipid Nanoparticles (LNP) Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Lipid Nanoparticles (LNP) Revenue and Market Share by Region (2019-2024) 4.2.2 Global Lipid Nanoparticles (LNP) Revenue Forecast by Region (2025-2030) 5 Global Lipid Nanoparticles (LNP) Market Size by Type and Application 5.1 Global Lipid Nanoparticles (LNP) Market Size by Type 5.2 Global Lipid Nanoparticles (LNP) Market Size by Application 6 North America 6.1 North America Lipid Nanoparticles (LNP) Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Lipid Nanoparticles (LNP) Market Size by Type 6.4 North America Lipid Nanoparticles (LNP) Market Size by Application 6.5 North America Lipid Nanoparticles (LNP) Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Lipid Nanoparticles (LNP) Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Lipid Nanoparticles (LNP) Market Size by Type 7.4 Europe Lipid Nanoparticles (LNP) Market Size by Application 7.5 Europe Lipid Nanoparticles (LNP) Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Lipid Nanoparticles (LNP) Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Lipid Nanoparticles (LNP) Market Size by Type 8.4 China Lipid Nanoparticles (LNP) Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Lipid Nanoparticles (LNP) Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Lipid Nanoparticles (LNP) Market Size by Type 9.4 APAC (excl. China) Lipid Nanoparticles (LNP) Market Size by Application 9.5 APAC (excl. China) Lipid Nanoparticles (LNP) Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Lipid Nanoparticles (LNP) Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Lipid Nanoparticles (LNP) Market Size by Type 10.4 Latin America Lipid Nanoparticles (LNP) Market Size by Application 10.5 Latin America Lipid Nanoparticles (LNP) Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Lipid Nanoparticles (LNP) Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Type 11.4 Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Application 11.5 Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Lipid Nanoparticles (LNP) Market Revenue by Key Manufacturers (2020-2024) 12.2 Lipid Nanoparticles (LNP) Competitive Landscape Analysis and Market Dynamic 12.2.1 Lipid Nanoparticles (LNP) Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Precision NanoSystems 13.1.1 Precision NanoSystems Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Precision NanoSystems Lipid Nanoparticles (LNP) Product Portfolio 13.1.3 Precision NanoSystems Lipid Nanoparticles (LNP) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Evonik 13.2.1 Evonik Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Evonik Lipid Nanoparticles (LNP) Product Portfolio 13.2.3 Evonik Lipid Nanoparticles (LNP) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Merck KGaA 13.3.1 Merck KGaA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Merck KGaA Lipid Nanoparticles (LNP) Product Portfolio 13.3.3 Merck KGaA Lipid Nanoparticles (LNP) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Genevant Sciences 13.4.1 Genevant Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Genevant Sciences Lipid Nanoparticles (LNP) Product Portfolio 13.4.3 Genevant Sciences Lipid Nanoparticles (LNP) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Exelead 13.5.1 Exelead Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Exelead Lipid Nanoparticles (LNP) Product Portfolio 13.5.3 Exelead Lipid Nanoparticles (LNP) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Avanti Polar Lipids 13.6.1 Avanti Polar Lipids Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Avanti Polar Lipids Lipid Nanoparticles (LNP) Product Portfolio 13.6.3 Avanti Polar Lipids Lipid Nanoparticles (LNP) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Nippon Fine Chemical 13.7.1 Nippon Fine Chemical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Nippon Fine Chemical Lipid Nanoparticles (LNP) Product Portfolio 13.7.3 Nippon Fine Chemical Lipid Nanoparticles (LNP) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Lipoid 13.8.1 Lipoid Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Lipoid Lipid Nanoparticles (LNP) Product Portfolio 13.8.3 Lipoid Lipid Nanoparticles (LNP) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Lipid Nanoparticles (LNP) Industry Chain Analysis 14.2 Lipid Nanoparticles (LNP) Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Lipid Nanoparticles (LNP) Typical Downstream Customers 14.4 Lipid Nanoparticles (LNP) Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support